Online citations, reference lists, and bibliographies.
← Back to Search

Cancer Survival In Five Continents: A Worldwide Population-based Study (CONCORD).

M. Coleman, M. Quaresma, F. Berrino, Jean-Michel Lutz, R. de Angelis, R. Capocaccia, P. Baili, B. Rachet, G. Gatta, T. Hakulinen, Andrea Micheli, M. Sant, H. Weir, J. M. Elwood, H. Tsukuma, S. Koifman, G. A. e Silva, S. Francisci, M. Santaquilani, A. Verdecchia, H. Storm, J. L. Young
Published 2008 · Medicine, Geography

Save to my Library
Download PDF
Analyze on Scholarcy
Share
BACKGROUND Cancer survival varies widely between countries. The CONCORD study provides survival estimates for 1.9 million adults (aged 15-99 years) diagnosed with a first, primary, invasive cancer of the breast (women), colon, rectum, or prostate during 1990-94 and followed up to 1999, by use of individual tumour records from 101 population-based cancer registries in 31 countries on five continents. This is, to our knowledge, the first worldwide analysis of cancer survival, with standard quality-control procedures and identical analytic methods for all datasets. METHODS To compensate for wide international differences in general population (background) mortality by age, sex, country, region, calendar period, and (in the USA) ethnic origin, we estimated relative survival, the ratio of survival noted in the patients with cancer, and the survival that would have been expected had they been subject only to the background mortality rates. 2800 life tables were constructed. Survival estimates were also adjusted for differences in the age structure of populations of patients with cancer. FINDINGS Global variation in cancer survival was very wide. 5-year relative survival for breast, colorectal, and prostate cancer was generally higher in North America, Australia, Japan, and northern, western, and southern Europe, and lower in Algeria, Brazil, and eastern Europe. CONCORD has provided the first opportunity to estimate cancer survival in 11 states in USA covered by the National Program of Cancer Registries (NPCR), and the study covers 42% of the US population, four-fold more than previously available. Cancer survival in black men and women was systematically and substantially lower than in white men and women in all 16 states and six metropolitan areas included. Relative survival for all ethnicities combined was 2-4% lower in states covered by NPCR than in areas covered by the Surveillance Epidemiology and End Results (SEER) Program. Age-standardised relative survival by use of the appropriate race-specific and state-specific life tables was up to 2% lower for breast cancer and up to 5% lower for prostate cancer than with the census-derived national life tables used by the SEER Program. These differences in population coverage and analytical method have both contributed to the survival deficit noted between Europe and the USA, from which only SEER data have been available until now. INTERPRETATION Until now, direct comparisons of cancer survival between high-income and low-income countries have not generally been available. The information provided here might therefore be a useful stimulus for change. The findings should eventually facilitate joint assessment of international trends in incidence, survival, and mortality as indicators of cancer control.
This paper references
10.2307/2529873
Cancer survival corrected for heterogeneity in patient withdrawal.
T. Hakulinen (1982)
10.1016/S1470-2045(07)70246-2
Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
A. Verdecchia (2007)
SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD,
Ries Lag (2006)
The Natural Duration of Lung Cancer.
(1955)
SEER Cancer Statistics Review, 1975-2003
L. Ries (2006)
10.1093/PUBMED/22.3.343
An international comparison of cancer survival: relatively poor areas of Toronto, Ontario and three US metropolitan areas.
K. Gorey (2000)
Cancer survival, Victoria, 2007: estimates of survival in 2004 and comparisons with earlier periods
DR English (2007)
10.1007/978-2-287-39310-5
Survie des patients atteints de cancer en France
P. Grosclaude (2007)
10.1002/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M
Estimates of the worldwide mortality from 25 cancers in 1990
P. Pisani (1999)
[Screening for prostate cancer--what does the evidence show?].
M. Borre (2007)
CONCORD study Cancer Research UK Cancer Survival Group
Working Group (2008)
10.1038/sj.bjc.6602506
Choice of geographic unit influences socioeconomic inequalities in breast cancer survival
L. Woods (2005)
10.1093/JNCI/91.22.1933
Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project.
J. Dignam (1999)
10.1007/978-3-642-85851-2
Cancer Incidence in Five Continents
Freddie Ian Bray (1970)
112 United Nations. Demographic Yearbook
(1992)
10.1093/ANNONC/MDG750
The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies.
F. Berrino (2003)
10.1093/ANNONC/MDG030
Evidence-based management options for women at increased breast/ovarian cancer risk.
G. Pichert (2003)
10.1002/cncr.10833
Childhood cancer survival in Europe and the United States
G. Gatta (2002)
10.1093/ANNONC/MDG035
Off label use--label off use?
J. Boos (2003)
10.1016/S1470-2045(07)70247-4
EUROCARE-4 studies bring new data on cancer survival.
M. Richards (2007)
Milan: EUROCARE Working Group
(2003)
10.1007/s10552-004-1555-5
Rationale and design of the National Program of Cancer Registries' breast, colon, and prostate cancer patterns of care study
K. McDavid (2004)
Cathepsin B expression is similar in African-American and Caucasian prostate cancer patients.
A. Sinha (2007)
10.1080/028418698423177
Relative survival of cancer patients--a comparison between Denmark and the other Nordic countries.
A. Engeland (1998)
10.3109/02841868909092281
Progress against cancer: are we winning the war?
R. Doll (1989)
Comparison of the coding of death certificates related to cancer in seven countries.
C. Percy (1978)
10.1177/030089160809400503
Life Tables for World-Wide Comparison of Relative Survival for Cancer (CONCORD Study)
P. Baili (2008)
Cancer survival trends in England and Wales 1971–1995: deprivation and NHS Region
MP Coleman (1999)
10.1016/J.EJCA.2007.01.007
Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates.
D. Robinson (2007)
10.1002/cncr.20038
Breast carcinoma survival in Europe and the United States
M. Sant (2004)
10.1002/cncr.21995
Hodgkin disease survival in Europe and the U.S.
C. Allemani (2006)
10.1093/JNCI/94.7.490
Race, socioeconomic status, and breast cancer treatment and survival.
C. Bradley (2002)
Calculation of survival rates for cancer.
J. Berkson (1950)
Stat—cancer incidence public use database 1973–95
An overview of cancer survival in developing countries.
R. Sankaranarayanan (1998)
10.1016/J.EJCA.2006.07.021
Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).
N. Bossard (2007)
10.1093/EURPUB/13.SUPPL_1.1
Monitoring health in Europe: opportunities, challenges and progress.
M. McKee (2003)
EUROCARE-3: the survival of cancer patients diagnosed in Europe during 1990–94
F Berrino (2003)
Screening for prostatacancer--hvad siger evidensen?
M. Borre (2007)
Cancer survival trends in England and Wales 1971-1995: deprivation and NHS Region
MP Coleman (1999)
Overview of EUROCARE-2 results on survival of cancer patients diagnosed 1985-89
M Sant (1999)
A comparison of nationwide cancer survival statistics in Finland and Norway.
T. Hakulinen (1983)
10.1002/(SICI)1097-0142(19961215)78:12<2461::AID-CNCR2>3.0.CO;2-N
Global variations in cancer survival
R. Sankaranarayanan (1996)
Trends in cancer incidence and mortality
R. Doll (1994)
10.3322/canjclin.50.1.50
Differences in breast cancer prognosis among African‐American and Caucasian women
J. Dignam (2000)
Basic issues in estimating and comparing the survival of cancer patients.
F. Berrino (1995)
111 United Nations. Demographic Yearbook
(1995)
Breast carcinoma survival in Europe and the USA: a population-based study
M Sant (2004)
10.1002/SIM.1970
Funnel plots for comparing institutional performance.
D. Spiegelhalter (2005)
Prostatacancer 2006—status og nye udfordringer 122 Ministry of Health Labour and Welfare. National survey on the life of the people Ministry of Health, Labour and Welfare Statistical Database
Urologisk Dansk (1243)
10.1093/ANNONC/MDJ007
Origins of socio-economic inequalities in cancer survival: a review.
L. Woods (2006)
10.1093/JNCI/73.2.341
Cancer patient survival among ethnic groups in the United States.
J. L. Young (1984)
10.1002/1097-0142(19931115)72:10<2974::AID-CNCR2820721019>3.0.CO;2-M
Race, income, and survival from breast cancer at two public hospitals
D. Ansell (1993)
10.1093/JNCI/94.5.334
Racial and ethnic disparities in the receipt of cancer treatment.
V. Shavers (2002)
10.1007/978-3-642-83693-0
Histological Typing of Intestinal Tumours
Dr. J. R. Jass (1989)
10.1093/ANNONC/MDG754
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.
M. Sant (2003)
10.1093/JNCI/91.22.1908
Race and outcomes: is this the end of the beginning for minority health research?
O. Brawley (1999)
Survival of cancer patients in Europe: the EUROCARE-3 study (CDROM)
F Berrino (2003)
10.1093/ANNONC/MDG755
Childhood cancer survival in Europe.
G. Gatta (2003)
10.1136/BMJ.2.3320.266
THE NATURAL DURATION OF CANCER
W. S. Lazarus-Barlow (1924)
Apparent changes in cancer mortality, 1968. A study of the effects of the introduction of the Eighth Revision International Classification of Diseases.
C. Percy (1974)
10.1016/S0936-6555(05)81065-9
Are we winning the war against cancer? A review in memory of Keith Durrant.
R. Doll (1992)
United States cancer statistics; 2004 incidence and mortality
U. Ajani (2007)
10.1016/0021-9681(77)90036-4
On long-term relative survival rates.
T. Hakulinen (1977)
10.1016/0277-5379(90)90025-O
Are we winning the fight against cancer? An epidemiological assessment. EACR--Mühlbock memorial lecture.
R. Doll (1990)
10.1080/13557858.1996.9961771
Race, socioeconomic status and survival in three female cancers.
H. Greenwald (1996)
10.1016/S0033-3506(97)00571-4
Demographic yearbook 1992: the disease picture of the developed and developing worlds compared.
C. Brockington (1997)
10.1007/BF00052188
Survival of cancer patients in europe—The EUROCARE study
F. Pannelli (2004)
Social inequalities and cancer
M. Kogevinas (1997)
The CONCORD protocol (rev
MP Coleman (2001)
Vol 1. Incidence. Sacramento, CA: North American Association of Central Cancer Registries The CONCORD protocol (rev. 2001). CONCORD Steering Committee
Vw Chen (1991)
Survival of cancer patients in Europe: the EUROCARE-3 study [Journal supplement issue]
F. Berrino (2003)
Socioeconomic differences in cancer survival: a review of the evidence.
M. Kogevinas (1997)
10.1016/S0090-4295(97)00705-X
Prostate cancer in Denmark: a 50-year population-based study.
K. Brasso (1998)
International differences in breast cancer survival and "cure" by social deprivation : a comparative study of England and Australia.
L. M. Woods (2006)
10.1038/sj.bjc.6602154
Comparison of cancer survival in UK and Australia: rates are higher in Australia for three major sites
X. Yu (2004)
CONCORD study : comparable life tables for world - wide analysis of relative survival for cancer
P Baili
10.1038/bjc.1995.363
Limitations of the death certificate only index as a measure of incompleteness of cancer registration
H. Brenner (1995)
A report on the survival of the patients treated for cancer from 1935 to 1947 inclusive.
N. Mccormick (1953)
Overview of EUROCARE-2 results on survival of cancer patients diagnosed 1985-89
M Sant (1999)
Cancer incidence in five continents. Volume VII.
M. Curado (1997)
10.1007/978-3-642-83693-0_2
Histological Classification of Intestinal Tumours
J. Jass (1989)
10.1093/eurpub/ckn022
Patient survival for all cancers combined as indicator of cancer control in Europe.
A. Verdecchia (2008)
10.1136/gut.2004.044214
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery
L. Ciccolallo (2005)
10.1023/A:1014380323037
Projecting SEER cancer survival rates to the US: an ecological regression approach
A. Mariotto (2004)
Articles 26 www.thelancet.com/oncology Published online July 17
10.1093/eurpub/13.suppl_3.116
Cancer control in Europe: a proposed set of European cancer health indicators.
Andrea Micheli (2003)
10.1038/nrc1948
The evolution of the population-based cancer registry
D. Parkin (2006)
10.1002/(SICI)1097-0215(19991210)83:6<870::AID-IJC35>3.0.CO;2-9
Erratum: Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18–29 (1999).
P. Pisani (1999)
10.1093/ANNONC/MDG751
The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis.
R. Capocaccia (2003)
10.1016/j.ejca.2007.12.016
Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States.
M. Sant (2008)
10.1136/JCP.34.6.692-D
International Histological Classification of Tumours
R. Weller (1981)
10.1136/jech.2004.030965
Breast cancer survival in South Asian women in England and Wales
Sabya Farooq (2005)
10.1016/S1470-2045(07)70245-0
Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study.
F. Berrino (2007)
Incidence—SEER 9 public-use data, 2002: cases diagnosed 1973–2000
(2008)
Measurement of progress against cancer. Extramural Committee to Assess Measures of Progress Against Cancer.
E. Sondik (1990)
Survival of cancer patients diagnosed in 1993–99: a collaborative study of population-based cancer registries in Japan
W Ajiki (2008)
10.1002/ijc.20471
Cancer survival in a southern African urban population
A. Gondos (2004)
Cancer survival trends in England and Wales 1971–1995: deprivation and NHS Region. (Studies on Medical and Population Subjects No. 61). London: The Stationery Office
Mp Coleman (1999)
The relative survival rate: a statistical methodology.
F. Ederer (1961)
10.1038/bjc.1992.193
Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year.
J. Richardson (1992)
10.1002/IJC.2910470402
Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely
E. P. Van Deresch (1991)
45 National Cancer Institute SEER*Stat software. Version 6.3.5. Bethesda, MD: National Cancer Institute
(2007)
10.1038/sj.bjc.6601097
Survival from breast cancer among South Asian and non-South Asian women resident in South East England
I. Dos Santos Silva (2003)
10.1002/(SICI)1097-0142(19980101)82:1<60::AID-CNCR7>3.0.CO;2-O
Differences in the diagnostic criteria used by japanese and western pathologists to diagnose colorectal carcinoma
R. Schlemper (1998)
Accuracy of statements of the cause of death on death certificates and the international comparability of mortality statistics
R Laurenti (2000)
10.1016/S0140-6736(05)73966-0
Trends in breast cancer incidence, survival, and mortality
J. Benson (2000)
10.1056/NEJM198605083141905
Progress against cancer?
J. Bailar (1986)
The evolution of the population - based cancer registry
A Verdecchia (2006)
10.1001/ARCHINTE.163.18.2135
Cancer survival in Kentucky and health insurance coverage.
K. McDavid (2003)
10.1023/A:1026793615987
Childhood cancer survival in Cuba
M. G. Boschmonar (2004)
10.1186/bcr932
The changing global patterns of female breast cancer incidence and mortality
F. Bray (2004)
10.13016/1BBM-D7BQ
Unequal Treatment: Con-fronting Racial and Ethnic Disparities in Health Care
B. Smedley (2002)
10.1016/S0959-8049(03)00549-5
Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology.
G. Gatta (2003)
10.1016/S0959-8049(03)00360-5
Comparison of stomach cancer incidence and survival in four continents.
A. Verdecchia (2003)
Survival of blacks and whites after a cancer diagnosis.
P. Walsh (2002)
10.1016/S0046-8177(98)90385-9
Pathology of the malignant colorectal polyp.
H. Cooper (1998)
National survey on the life of the people , 2004
DM Parkin
[Prostatic cancer 2006--status and new challenges. The Danish Society of Urology].
K. Brasso (2006)
10.1093/JNCI/94.7.471
Disaggregating the effects of race and poverty on breast cancer outcomes.
O. Brawley (2002)
Cancer survival in Cuba.
L. Fernández Garrote (1998)
10.1093/ANNONC/MDG756
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.
M. Coleman (2003)
Publications from the EUROCARE study. EUROCARE Working Group
Working Group (2007)
Cancer Survival in Developing Countries
R. Sankaranarayanan (1998)
10.1002/SIM.4780090506
Relative survival and the estimation of net survival: elements for further discussion.
J. Estève (1990)
10.1016/0021-9681(58)90126-7
Maximum utilization of the life table method in analyzing survival.
S. J. Cutler (1958)
10.3109/9780415874984-2
Trends in cancer incidence and mortality.
M. Coleman (1993)
10.1016/0895-4356(96)00176-X
Regional variation in survival following the diagnosis of cancer.
D. C. Farrow (1996)
Cancer incidence in five continents. Volume VIII.
(2002)
Cancer incidence in five continents : a technical report
R. Doll (1966)
10.1136/jcp.30.8.782-c
International Classification of Diseases for Oncology
P. Trott (1977)
10.1001/JAMA.290.18.2487-B
Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare
L. Capps (2003)
Prostatacancer 2006--status og nye udfordringer. Dansk Urologisk Selskab
K. Brasso (2006)
10.3322/canjclin.54.2.78
Cancer Disparities by Race/Ethnicity and Socioeconomic Status
E. Ward (2004)
10.1093/JNCI/87.22.1686
Determinants of black/white differences in colon cancer survival.
R. Mayberry (1995)
Cancer survival, incidence and mortality by Area Health Service in NSW 1994 to 2000
X. Yu (2003)
EUROCARE-3: the survival of cancer patients diagnosed in Europe
F Berrino
10.1002/cncr.10645
Socioeconomic and demographic disparities in treatment for carcinomas of the colon and rectum
J. Vaneenwyk (2002)
Studies on medical and population subjects.
A. Adelstein (1976)
Measurement of progress against cancer
MP Coleman (2000)
10.1056/nejm199705293362206
Cancer undefeated.
J. Bailar (1997)
10.1111/j.1572-0241.2007.01337.x
Hepatocellular Carcinoma: Trends of Incidence and Survival in Europe and the United States at the End of the 20th Century
R. Capocaccia (2007)
10.1002/1097-0142(20000815)89:4<893::AID-CNCR24>3.0.CO;2-9
Toward a comparison of survival in American and European cancer patients
G. Gatta (2000)
Countries and states by UN region. United Nations
(2008)
Estimates of the worldwide mortality from 25 major cancers
P Pisani (1990)
The CONCORD protocol (rev
MP Coleman (2001)
Overview of EUROCARE-2 results on survival of cancer patients diagnosed 1985-89 Survival of cancer patients in Europe: the EUROCARE-2 study
M Sant (1999)
World standard cancer patient populations: a resource for comparative analysis of survival data.
Black Rj (1998)
Ann Oncol
(2003)
10.1111/j.1572-0241.2003.07448.x
Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System
L. Rabeneck (2003)
Comparability and Quality Control in Cancer Registration; Karachi (data monitoring 1995-2001).
Y. Bhurgri (2002)
10.1016/J.EJCA.2004.07.002
Standard cancer patient population for age standardising survival ratios.
I. Corazziari (2004)
10.1097/01.OGX.0000314816.42514.F5
Association of Insurance Status and Ethnicity With Cancer Stage at Diagnosis for 12 Cancer Sites: A Retrospective Analysis
M. Halpern (2008)
Cancer survival in Cuba.
L. Fernández-Garrote (1998)
Cancer survival, Victoria, 2007: estimates of survival in 2004 and comparisons with earlier periods. Melbourne: The Cancer Council Victoria
Dr English (2007)
Comparison between registries: age-standardized rates
P. Smith (1992)
10.1093/JJCO/HYL068
Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan.
H. Tsukuma (2006)
10.17269/CJPH.89.1048
An international comparison of cancer survival: advantage of Toronto's poor over the near poor of Detroit.
K. Gorey (1998)



This paper is referenced by
10.5539/gjhs.v8n9p1
Assessment of Quality of Life of Women with Breast Cancer
Z. Gavric (2016)
10.2147/CLEP.S32004
Completeness of prostate cancer staging in the Danish Cancer Registry, 2004–2009
Mary Nguyen-Nielsen (2012)
10.21149/SPM.V56I5.7371
Incidencia, mortalidad y supervivencia por cáncer colorrectal en Cali, Colombia, 1962-2012
A. Cortés (2014)
10.1002/lary.26836
Urban and rural differences in outcomes of head and neck cancer
J. Kim (2018)
Breast cancer survival and stage at diagnosis in Australia , Canada , Denmark , Norway , Sweden and the UK , 2000-2007
C. Maringe (2013)
Knowledge, attitude and preventive practices of women for breast cancer in the educational institutions of Lahore, Pakistan.
S. Khokher (2011)
10.1016/B978-0-12-801238-3.64169-7
Detection and Classification of Breast Lesions Using Ultrasound-Based Imaging Modalities
Md. Kamrul Hasan (2014)
ASSOCIATION OF METFORMIN WITH BREAST CANCER INCIDENCE AND MORTALITY: A SYSTEMATIC REVIEW AND META-ANALYSIS
Grace Tang (2017)
Differences in Inflammatory Breast Cancer Characteristics and Outcomes Between Caucasian and Hispanic Women in the US
(2018)
10.26719/2020.26.2.219
Survival rates of patients with breast cancer in countries in the Eastern Mediterranean Region: a systematic review and meta-analysis.
Khadije Maajani (2020)
10.1007/978-2-8178-0389-0_26
Stratégie diagnostique devant une insuffisance respiratoire aiguë chez un patient d’oncohématologie admis en réanimation
D. Schnell (2013)
10.1016/j.rehab.2014.03.583
Long-term improved quality of life by a 2-week group physical and educational intervention shortly after breast cancer chemotherapy completion. Results of the “Programme of Accompanying women after breast Cancer treatment completion in Thermal resorts” (PACTHE)
F. Kwiatkowski (2014)
10.1016/S0140-6736(14)62038-9
Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
C. Allemani (2015)
10.1371/journal.pone.0039589
High Rates of Obesity and Non-Communicable Diseases Predicted across Latin America
L. Webber (2012)
10.1038/bjc.2012.169
Avoidable deaths and random variation in patients' survival
K. Seppä (2012)
10.1016/j.dld.2011.10.003
Volume of surgical activity and lymph node evaluation for patients with colorectal cancer in France.
O. Dejardin (2012)
10.1111/j.1464-410X.2011.10188.x
Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study
K. Matsumoto (2011)
10.1038/bjc.2013.6
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study
S. Walters (2013)
10.1007/S11482-018-9622-3
A Structural Model for Adjustment to Aging among Older Women in Breast Cancer Remission
S. V. Humboldt (2019)
10.1186/s12885-019-5442-6
Prognostic models for breast cancer: a systematic review
Minh Tung Phung (2019)
10.1016/J.SNB.2018.07.029
Advanced antifouling zwitterionic layer based impedimetric HER2 biosensing in human serum: Glycoprofiling as a novel approach for breast cancer diagnostics
Erika Chocholova (2018)
Méthodes d'analyse de la survie nette : utilisation des tables de mortalité, test de comparaison et détection d'agrégats spatiaux
N. Grafféo (2014)
10.1016/j.jddst.2020.101662
Advances in anti-breast cancer drugs and the application of nano-drug delivery systems in breast cancer therapy
Xiaolin Fang (2020)
10.1016/j.ejps.2020.105401
Understanding Breast cancer: from conventional therapies to repurposed drugs.
B. Costa (2020)
10.1111/opn.12054
Breast cancer threat appraisal: design and psychometric analysis of a new scale for older women.
R. Y. Wood (2015)
10.2147/PRBM.S241431
The Effect of CoQ10 Supplementation on Quality of Life in Women with Breast Cancer Undergoing Tamoxifen Therapy: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
S. A. Hosseini (2020)
10.1093/cvr/cvz197
Statistics on mortality following acute myocardial infarction in 842,897 Europeans.
O. Alabas (2019)
10.1002/PAM.22035
MEDICARE‐FOR‐ALL: NOT OUR ONLY OPTION FOR UNIVERSAL COVERAGE
D. Goldman (2018)
In Vitro and In Silico Anti-Breast Cancer Analysis of Bioactive Metabolites of Bacillus subtilis Isolated From Soil
Ram Kumar (2020)
10.1097/DCR.0b013e31825afc4e
The Incidence and Survival Rates of Colorectal Cancer in India Remain Low Compared With Rising Rates in East Asia
S. Pathy (2012)
Supervivencia del cáncer de mama
Lourdes Beatriz González Longoria Boada. (2011)
Incidence and Mortality of Colorectal Cancer and Relationships with the Human Development Index across the World.
H. Rafiemanesh (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar